Dibenamine hydrochloride NEW
| Price | $29 |
| Package | 500mg |
| Supply Ability: | 10g |
| Update Time: | 2026-07-07 |
Product Details
| Product Name: Dibenamine hydrochloride | CAS No.: 55-43-6 |
| Purity: 98.34% | Supply Ability: 10g |
| Release date: 2026/07/07 |
Product Introduction
Bioactivity
| Name | Dibenamine hydrochloride |
| Description | Dibenamine hydrochloride is a competitive and irreversible blocker of the β-adrenergic receptor. |
| In vitro | The irreversible inhibitory effects of dibenamine on the noradrenaline-, K- and Ba-induced contractions of rat's isolated vas deferens, particularly in relation to Ca. |
| In vivo | Dibenamine hydrochloride causes a significant increase in the rate of destruction of L-epinephrine in the mouse. Pretreatment with Dibenamine hydrochloride apparently slowed the conversion of Ccl4 to CHCL3. Dibenamine hydrochloride (25 mg/kg; s.c.) decreased the CHCl3, levels at 2 and 6 hr by 30%-50%[3]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 125 mg/mL (421.97 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 4 mg/mL (13.5 mM), Sonication is recommended. H2O : 33.33 mg/mL (112.51 mM), Sonication is recommended. |
| Keywords | β-adrenergic receptor | Inhibitor | inhibit | hepatotoxicity | epinephrine | Dibenamine hydrochloride | Dibenamine | Beta Receptor | AdrenergicReceptor | Adrenergic Receptor | adrenergic | Acetylcholine |
| Inhibitors Related | Trifluoperazine dihydrochloride | Mirtazapine | Octopamine hydrochloride | Gemfibrozil | Buflomedil hydrochloride | Dexmedetomidine hydrochloride | Isoprenaline hydrochloride | D-Mannitol | Mianserin hydrochloride | Trazodone hydrochloride | Atenolol | Doxepin hydrochloride |
| Related Compound Libraries | Bioactive Compound Library | Neuronal Signaling Compound Library | Membrane Protein-targeted Compound Library | Neurotransmitter Receptor Compound Library | Inhibitor Library | Endocrinology-Hormone Compound Library | Anti-Cardiovascular Disease Compound Library | Bioactive Compounds Library Max | Adrenergic Receptor-Targeted Compound Library | GPCR Compound Library | Anti-Cancer Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $2500.00 |
VIP2Y
|
TargetMol Chemicals Inc.
|
2026-04-21 | |
| $2.00 |
VIP2Y
|
ZHENGZHOU JIUYI TIME NEW MATERIALS CO,.LTD
|
2026-07-02 | |
|
VIP4Y
|
Dingwang Technology (Wuhan) Co., Ltd.
|
2025-08-22 | ||
| $1.10 |
VIP6Y
|
Dideu Industries Group Limited
|
2025-11-18 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY